ADC Therapeutics SA financial data

Symbol
ADCT on NYSE
Industry
Pharmaceutical Preparations
Location
Biopole, Route De La Corniche 3 B, Epalinges, Switzerland
State of incorporation
Switzerland
Fiscal year end
December 31
Latest financial report
Q4 2023 - Mar 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Operating Margin -239 % -306%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.5M shares
Common Stock, Shares, Outstanding 82.3M shares +2.05%
Entity Public Float 153M USD
Common Stock, Value, Issued 7.31M USD 0%
Weighted Average Number of Shares Outstanding, Basic 81.7M shares +4.55%
Weighted Average Number of Shares Outstanding, Diluted 81.7M shares +4.55%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 69.6M USD -66.9%
Revenue from Contract with Customer, Excluding Assessed Tax 69.1M USD -7.81%
Cost of Revenue 2.53M USD -23.4%
Research and Development Expense 127M USD -31.8%
Selling and Marketing Expense 57.5M USD -16.8%
General and Administrative Expense 48.4M USD -35%
Costs and Expenses 236M USD -29.3%
Operating Income (Loss) -166M USD -34.6%
Nonoperating Income (Expense) -29.4M USD -25.4%
Income Tax Expense (Benefit) 39.1M USD +17127%
Net Income (Loss) Attributable to Parent -240M USD -52.8%
Earnings Per Share, Basic -2.94 USD/shares -46.3%
Earnings Per Share, Diluted -2.94 USD/shares -46.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 279M USD -14.7%
Inventory, Net 16.2M USD +34%
Assets, Current 336M USD -22.7%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 5.62M USD +67.6%
Operating Lease, Right-of-Use Asset 10.5M USD +52.2%
Other Assets, Noncurrent 711K USD -21.2%
Assets 355M USD -27.7%
Accounts Payable, Current 15.6M USD +26.1%
Accrued Liabilities, Current 50.6M USD -26.1%
Liabilities, Current 67.7M USD -17.4%
Deferred Income Tax Liabilities, Net 1.33M USD -66.7%
Operating Lease, Liability, Noncurrent 10.2M USD +55.1%
Other Liabilities, Noncurrent 8.88M USD +960%
Liabilities 503M USD +22.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -93K USD -105%
Retained Earnings (Accumulated Deficit) -1.34B USD -21.9%
Stockholders' Equity Attributable to Parent -148M USD -287%
Liabilities and Equity 355M USD -27.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -119M USD +14.2%
Net Cash Provided by (Used in) Financing Activities 73.9M USD
Net Cash Provided by (Used in) Investing Activities -3.22M USD -368%
Common Stock, Shares, Issued 89M shares 0%
Common Stock, Par or Stated Value Per Share 0.08 CHF/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 279M USD -14.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 15.4M USD +51.2%
Deferred Tax Assets, Valuation Allowance 212M USD +61.7%
Deferred Tax Assets, Gross 213M USD +23.9%
Operating Lease, Liability 11.6M USD
Depreciation 1.19M USD +12%
Payments to Acquire Property, Plant, and Equipment 3.22M USD +368%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -242M USD -57.6%
Lessee, Operating Lease, Liability, to be Paid 13.7M USD
Property, Plant and Equipment, Gross 9.9M USD +46.3%
Operating Lease, Liability, Current 1.47M USD +33.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.94M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.96M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +76.9%
Deferred Income Tax Expense (Benefit) 37.1M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.01M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.98M USD
Deferred Tax Assets, Operating Loss Carryforwards 163M USD +24.2%
Current Income Tax Expense (Benefit) 2M USD +8.33%
Unrecognized Tax Benefits 6.62M USD +27.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.99M USD
Additional Paid in Capital 1.18B USD +1.21%
Deferred Tax Assets, Net of Valuation Allowance 1.33M USD -96.8%
Interest Expense 46.3M USD +26.1%